Priority Date: 15.06.11 (US 201161497356P)
COMBINATION THERAPIES FOR TREATING HEMATOLOGIC MALIGNANCIES USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K/MTOR WITH BENDAMUSTINE AND/OR RITUXIMAB
- Application ID: EP12731817
- Status: █ APPLICATION DEEMED TO BE WITHDRAWN
Attorney
operating since 1975
Headquarter in Glasgow
and
18 offices
active in Legal Services, IP Consulting, Matchmaking and Trading, and IP Portfolio Processing
Specialization
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Murgitroyd & Company is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
Timeline
- 15.06.2011 - Priority Date (US 201161497356P)
- 20.12.2012 - Publication A1 (WO2012174327)
- 29.10.2014 - Publication A1 (EP2793892)